MOHAMAD KASSAR, M.D.
Hematology & Oncology Physician · DYER, IN
Individual Active NPI 1063691830
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,225 | 501,703 | $44,471,853 | $12,471,411 | $9,978,429 |
| 2023 | 1,155 | 525,515 | $36,491,180 | $9,613,338 | $7,696,833 |
| 2022 | 1,093 | 556,136 | $36,757,395 | $10,013,798 | $8,019,958 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9025 | Injection, azacitidine, 1 mg | 48,155 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 41,280 | $31 | $25 |
| J0185 | Injection, aprepitant, 1 mg | 35,620 | $2 | $1 |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 35,000 | $27 | $22 |
| J9271 | Injection, pembrolizumab, 1 mg | 29,800 | $56 | $44 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 27,970 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 23,220 | $49 | $39 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 22,572 | $27 | $21 |
| J9267 | Injection, paclitaxel, 1 mg | 12,048 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 10,860 | $25 | $20 |
| Q5129 | Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | 9,258 | $62 | $49 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 8,050 | $47 | $37 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 01064684A | IN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Indiana
- NPI 1528294998
- NPI 1356508915
- NPI 1619210143
- NPI 1356514608
- NPI 1598342800
- NPI 1912977281
- NPI 1861525560
- NPI 1558364372
See all Hematology & Oncology Physician providers in Indiana →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.